CS logo
small CS logo
Kansas City Cancer Center-Shawnee Mission

Shawnee Mission, Kansas, United States

About Kansas City Cancer Center-Shawnee Mission


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Kansas City Cancer Center-Shawnee Mission


During the past decade, Kansas City Cancer Center-Shawnee Mission conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City Cancer Center-Shawnee Mission" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

Clinical Trials Conditions at Kansas City Cancer Center-Shawnee Mission


According to Clinical.Site data, the most researched conditions in "Kansas City Cancer Center-Shawnee Mission" are "Prostate Cancer" (3 trials), "Adenocarcinoma of the Gastroesophageal Junction" (2 trials), "Breast Cancer" (2 trials), "Bladder Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Kansas City Cancer Center-Shawnee Mission" in a lesser frequency.

Clinical Trials Intervention Types at Kansas City Cancer Center-Shawnee Mission


Most popular intervention types in "Kansas City Cancer Center-Shawnee Mission" are "Drug" (12 trials), "Other" (4 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "docetaxel" (3 trials), "Paclitaxel" (2 trials), "capecitabine" (2 trials), "gemcitabine hydrochloride" (2 trials) and "oxaliplatin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Kansas City Cancer Center-Shawnee Mission


The vast majority of trials in "Kansas City Cancer Center-Shawnee Mission" are 8 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Clinical Trials Status at Kansas City Cancer Center-Shawnee Mission


Currently, there are NaN active trials in "Kansas City Cancer Center-Shawnee Mission". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Kansas City Cancer Center-Shawnee Mission, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kansas City Cancer Center-Shawnee Mission, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".